Hamza Suria

2017

In 2017, Hamza Suria earned a total compensation of $4M as President, Chief Executive Officer and Director at ANAPTYSBIO, a 594% increase compared to previous year.

Compensation breakdown

Bonus$209,250
Option Awards$3,341,588
Salary$465,000
Other$600
Total$4,016,438

Suria received $3.3M in option awards, accounting for 83% of the total pay in 2017.

Suria also received $209.3K in bonus, $465K in salary and $600 in other compensation.

Rankings

In 2017, Hamza Suria's compensation ranked 2,557th out of 14,666 executives tracked by ExecPay. In other words, Suria earned more than 82.6% of executives.

ClassificationRankingPercentile
All
2,557
out of 14,666
83rd
Division
Manufacturing
891
out of 5,772
85th
Major group
Chemicals And Allied Products
236
out of 2,075
89th
Industry group
Drugs
181
out of 1,731
90th
Industry
Pharmaceutical Preparations
146
out of 1,333
89th
Source: SEC filing on April 26, 2018.

Suria's colleagues

We found three more compensation records of executives who worked with Hamza Suria at ANAPTYSBIO in 2017.

2017

Dominic Piscitelli

ANAPTYSBIO

Chief Financial Officer

2017

Marco Londei

ANAPTYSBIO

Chief Medical Officer

2017

Matthew Moyle

ANAPTYSBIO

Chief Scientific Officer

News

In-depth

You may also like